| Nicole Crowden, | |
|
908 W Judge Perez Dr, Suite D, Chalmette, LA 70043-4773 | |
| (504) 715-1856 | |
| (504) 210-0527 |
| Full Name | Nicole Crowden |
|---|---|
| Gender | Female |
| Speciality | Social Worker - Clinical |
| Location | 908 W Judge Perez Dr, Chalmette, Louisiana |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1225459696 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | 11118 (Louisiana) | Primary |
| Entity Name | Azalea Health Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043999170 PECOS PAC ID: 8628432028 Enrollment ID: O20230919002265 |
News Archive
The new school year means new clothes, new classes, new teachers - and the same old misery due to sneezing and wheezing for children who have allergies or asthma. From the class hamster to dust mites residing in carpet to germs from cold and flu viruses, asthma and allergy triggers lurk throughout the classroom.
BioCryst Pharmaceuticals, Inc. announced positive top-line results from its randomized, double-blind, multi-center, placebo-controlled Phase 2 study designed to evaluate the urate-lowering activity and safety of several doses of BCX4208 alone and in combination with selected doses of allopurinol administered once-daily.
Heart failure in children is an important cause of childhood health problems and death. The Children's Heart Failure Study Group of the Canadian Cardiovascular Society, in collaboration with the Canadian Pediatric Cardiology Association, has developed new guidelines to assist practitioners in primary care and emergency departments to recognize and successfully manage heart failure in children with undiagnosed heart disease and symptoms of possible heart failure.
Pro-Pharmaceuticals, Inc. has announced that the U.S. Food and Drug Administration (FDA) has granted an Investigational New Drug (IND) application for use of Davanat in combination with 5-FU to treat a breast cancer patient at the Brown Cancer Center in Louisville, Kentucky. Davanat also is being administered in Phase II clinical trials for first-line treatment of colorectal and biliary cancer patients.
Celgene International Sàrl announced that data from the planned second interim analysis (median follow-up of 21 months) of a phase III, randomized, double-blind study of continuous REVLIMID (lenalidomide) for the treatment of elderly patients with newly diagnosed multiple myeloma show improvement in progression-free survival, the primary endpoint of the study.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Nicole Crowden, 3701 Red Cypress Dr, New Orleans, LA 70131-8317 Ph: (504) 715-1856 | Nicole Crowden, 908 W Judge Perez Dr, Suite D, Chalmette, LA 70043-4773 Ph: (504) 715-1856 |
News Archive
The new school year means new clothes, new classes, new teachers - and the same old misery due to sneezing and wheezing for children who have allergies or asthma. From the class hamster to dust mites residing in carpet to germs from cold and flu viruses, asthma and allergy triggers lurk throughout the classroom.
BioCryst Pharmaceuticals, Inc. announced positive top-line results from its randomized, double-blind, multi-center, placebo-controlled Phase 2 study designed to evaluate the urate-lowering activity and safety of several doses of BCX4208 alone and in combination with selected doses of allopurinol administered once-daily.
Heart failure in children is an important cause of childhood health problems and death. The Children's Heart Failure Study Group of the Canadian Cardiovascular Society, in collaboration with the Canadian Pediatric Cardiology Association, has developed new guidelines to assist practitioners in primary care and emergency departments to recognize and successfully manage heart failure in children with undiagnosed heart disease and symptoms of possible heart failure.
Pro-Pharmaceuticals, Inc. has announced that the U.S. Food and Drug Administration (FDA) has granted an Investigational New Drug (IND) application for use of Davanat in combination with 5-FU to treat a breast cancer patient at the Brown Cancer Center in Louisville, Kentucky. Davanat also is being administered in Phase II clinical trials for first-line treatment of colorectal and biliary cancer patients.
Celgene International Sàrl announced that data from the planned second interim analysis (median follow-up of 21 months) of a phase III, randomized, double-blind study of continuous REVLIMID (lenalidomide) for the treatment of elderly patients with newly diagnosed multiple myeloma show improvement in progression-free survival, the primary endpoint of the study.
› Verified 7 days ago
Katherine S Grieshaber, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 1100 E Judge Perez Dr, Chalmette, LA 70043 Phone: 504-333-6988 | |
Jovel Finney, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 3101 Jean Lafitte Pkwy, Suite A, Chalmette, LA 70043 Phone: 504-610-0477 | |
Ms. Sharon James Sanders, MSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 8101 W Judge Perez Dr, Bldg. B, Chalmette, LA 70043 Phone: 504-278-7401 Fax: 504-278-7475 | |
Cornelia Cager Bonds, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 2626 Charles Dr, Chalmette, LA 70043 Phone: 504-278-4006 Fax: 504-278-4007 | |
Ms. Nicole Renee Meredith, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 8050 W Judge Perez Dr Ste 1300, Chalmette, LA 70043 Phone: 504-575-3712 | |
Mrs. Rachel Hetler Penn, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 2626 Charles Dr, Chalmette, LA 70043 Phone: 504-278-4006 Fax: 504-278-4007 |